Foxo1 and Smad proteins coregulate hepcidin transcription. (A) Analysis of Foxo binding sites (red) and Smad binding sites/BMP-responsive elements (green) in the 3000 bp upstream region of hepcidin gene transcription start site in different mammals. (B) In the murine Hamp1 promoter, a scheme summarizing the 2 predicted Foxo binding sites and their corresponding mutant forms. WT, wild-type Hamp1 promoter; Mut, Hamp1 promoter with mutated Foxo binding site (red). (C-D) ChIP-qPCR analysis of the interaction between Foxo1 and 2 Foxo binding sites in the murine Hamp1 promoter region under basal condition (C) or holo-Tf/BMP6/AS1842856–treated condition (D). Cells were treated with 10 μM AS1842856 1 hour before the addition of 20 ng/mL BMP6 and/or 30 μM holo-Tf (AS1842856, 7 hours; BMP6, 6 hours; holo-Tf, 6 hours). (E) As indicated in panel B, Hamp1 promoter luciferase reporter plasmids containing wild-type (WT) or mutated (Mut) Foxo binding sites were transfected into primary hepatocytes and assayed for their luciferase reporter activities (holo-Tf, 30 μM; BMP6, 20 ng/mL; 7 hours). (F) Immunoprecipitation (IP) and western blot analysis of the Foxo1-pSmad1/5/8 interaction in primary hepatocytes from 8-week-old male Foxo1LKO and Foxo1flox/flox mice (left) and 8-week-old male WT 129S2/SvPasCrl mice (right). (G) IP/western blot analysis of the Foxo1-pSmad1/5/8 interaction in the cytosol of primary hepatocytes from 8-week-old male Foxo1LKO and Foxo1flox/flox mice. (H) IP/western blot analysis of the Foxo1-pSmad1/5/8 interaction in the primary hepatocytes treated with holo-Tf and/or BMP6 (7 hours; holo-Tf, 30 μM; BMP6, 20 ng/mL). (I) Quantifications of Foxo1-pSmad1/5/8 interaction from results displayed in panel H. (J) A working model to elucidate the role of Foxo1 in hepatic hepcidin regulation. Primary hepatocytes were isolated from 8-week-old male WT 129S2/SvPasCrl mice. Results from ChIP-qPCR, luciferase assay, IP/western blot, and corresponding quantification analysis were all obtained from 3 independent biological replicates. ∗P < .05, ∗∗P < .01, ∗∗∗P < .001. The P value was calculated by the Student t test for 2 group comparison or the 1-way ANOVA with the Sidak post hoc test for multiple comparison. For panels D-E, multiple comparison test was separately performed in different Foxo binding sites or their mutations.